Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial

BACKGROUND: The aim of this study was to investigate the role of pre-treatment aspartate aminotransferase-lynphocyte ratio (ALRI) as a predictor of prognosis and treatment efficacy in patients with metastatic colorectal cancer (mCRC) enrolled in the prospective multicenter randomized ITACa (Italian...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Onco Targets Ther
Auteurs principaux: Casadei Gardini, Andrea, Scarpi, Emanuela, Orlandi, Elena, Tassinari, Davide, Leo, Silvana, Bernardini, Ilaria, Gelsomino, Fabio, Tamberi, Stefano, Ruscelli, Silvia, Vespignani, Roberto, Ronconi, Sonia, Frassineti, Giovanni Luca, Amadori, Dino, Passardi, Alessandro
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2018
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6120511/
https://ncbi.nlm.nih.gov/pubmed/30214231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S166614
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires